Get started
Author

Di Cui

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer
2019 · Yong Yu, Jingjing Qi, et al. · Theranostics · 66
PDF
High-Yield Human Induced Pluripotent Stem Cell-Derived Monocytes and Macrophages Are Functionally Comparable With Primary Cells
2021 · Di Cui, Alexandra Franz, et al. · Frontiers in Cell and Developmental Biology · 39
PDF
Targeting Wnt/β-Catenin Signaling by TET1/FOXO4 Inhibits Metastatic Spreading and Self-Renewal of Cancer Stem Cells in Gastric Cancer
2022 · Jingjing Qi, Di Cui, et al. · Cancers · 28
PDF
YY1 induced USP13 transcriptional activation drives the malignant progression of hepatocellular carcinoma by deubiquitinating WWP1
2025 · Qingwei Zhu, Zibo Yuan, et al. · Cellular & Molecular Biology Letters · 18
MicroRNAs and long non-coding RNAs in liver surgery: Diagnostic and therapeutic merits
2020 · Zhi-Qiu Hu, Yi Lu, et al. · Hepatobiliary & pancreatic diseases international · 12
Transcriptome profiling of tolerogenic dendritic cells conditioned with dual mTOR kinase inhibitor, AZD8055
2020 · Su Shao, Di Cui, et al. · International Immunopharmacology · 9
Prognostic and Immune Landscape Analysis of Ubiquitination-related Genes in Hepatocellular Carcinoma: Based on Bulk and Single-cell RNA Sequencing Data
2024 · Zibo Yuan, Qingwei Zhu, et al. · Journal of Cancer · 7
PDF
EPHX2 overexpression deters the advancement of clear cell renal cell carcinoma via lipid metabolism reprogramming
2025 · Bo Guan, Cong Huang, et al. · Frontiers in Oncology · 6
PDF
RARS1 inhibits ENO1 ubiquitination and degradation to protect against ferroptosis in hepatocellular carcinoma
2025 · Shouge Zang, Jvlong Ma, et al. · Frontiers in Immunology · 2
PDF
Bcl-xL Inhibition Disrupts p27 Stability and Promotes Senescence Escape: Insights for Cancer Senotherapy
2025 · Xiaobai He, Xiaopan Chen, et al. · Research Square
PDF
Works count: 10
Citation count: 187
H-index: 7
I10-index: 5
Year
Topic
Type